Simethicone: The Bubblebreaker.

Introduction

In the 1940s, farmers and breeders found cows dead on lush green pastures with no predator in sight. Farmers reported "bloat storms": sudden death events where healthy cattle dropped dead, seemingly of strangulation. This problem was so severe that H. H. Cole from UC Davis, a leading veterinary scientist, was appointed Chairman of a National Research Council subcommittee to resolve this issue. Using rumen fistulas (surgical "windows" that can peer into a cow's stomach), the team realized that the animals were dying because they could not burp out excessive gas—not because they were denied fresh air. Turns out, in the post-WWII era, Californian farmers had shifted towards a legume-rich diet for their cattle. These legumes had high levels of saponins and soluble proteins that trapped gas in the rumen's gut and created a "frothy broth". This "frothy broth" trapped gas bubbles generated inside the animal until it asphyxiated the animal from the inside.

Seeking a solution, the researchers looked to industry. Literally. Defoamers and antifoam agents are standard additives in the paint, textile, and food processing industry. One particular additive called simethicone or activated dimethicone or simply dimethicone was invaluable owing to its defoaming and lubricating properties. Its chemical inertness and low surface energy could potentially help defoam and break the deadly frothy broth in rumen. In a study by Quinn et al. (1949), injecting methylpolysiloxane into affected cattle led to recovery in 115 of 155 cases, confirming that the foam in bloat was nothing but air bubbles.

The leap of simethicone from industrial defoamer, lubricant, and hydrophobe, to pharmaceutical marvel began in veterinary medicine and human medicine soon followed.

In 1877, Kehrer suggested that gastric discomfort arose from air bubbles in swallowed food mass rather than a special "gastric vapor". Decades later, gastroenterologists noticed that trapped gas bubbles--like in cows!--interfered with endoscopic visibility and patient comfort (Morris et al., 1947). Early human trials with simethicone were strikingly successful: in one study of 200 patients aged 23–84, over 75% reported good to excellent relief after taking 40 mg of simethicone four times daily, with no significant side effects (Rider & Moeller, 1960).

The pivotal moment came in 1974 when Bernstein and Kasich published a double-blind, randomized, placebo-controlled trial demonstrating simethicone's clinical efficacy for upper gastrointestinal discomfort. Patients receiving simethicone experienced statistically significant improvements in both symptom frequency and severity compared to placebo (Bernstein & Kasich, 1974). This landmark study firmly established simethicone as a safe, effective, and purely physical solution. It did not alter chemistry, it literally broke bubbles.

The physics

Pour some water in a glass. Do it fast enough and you will see air bubbles rise and pop once they hit the surface. However, when there is a bit of detergent in the water, the air bubbles come to the surface and remain stable. The reason for this stability is the Marangoni flow.

Surfactant lowers surface tension at the air bubble-water interface. When a region of the air bubble-water interface stretches or depletes due to mechanical stresses or thermal fluctuations, the surfactant-water solution rushes in to repair the damage. This transport is driven by the surface tension gradient along the surface, otherwise known as the Marangoni flow. This is why bubbles in a soapy, foamy mesh are hard to get rid of--they are constantly repairing themselves!

Fundamentally, a defoamer frustrates Marangoni flow. Simethicone is hydrophobic and prefers proximity to the air bubble as opposed to bulk water, unlike the hydrophilic surfactant. Owing to its low surface tension, it spreads along the bubble-water interface. The hydrophobic droplet enters the surfactant-water interface and punctures it to contact the air. Simethicone is hydrophobic so the transport of the water-surfactant is energetically discouraged even though the interface is damaged. Since Marangoni flows cannot repair the interface anymore, the bubble pops and the air is released to the atmosphere.

In an enclosed system, the simethicone droplets bridge distinct air bubbles, disrupting the water-surfactant film that kept the foam mechanically intact. Visually, the bubbles coalesce, rise to a free surface, and the engorged bubble, subject to mechanical stresses and thermal fluctuations, pops!

Industrial and economic use

In 1952, the U.S. Food and Drug Administration (FDA) formally approved simethicone for human use after extensive safety and efficacy data demonstrated its inertness and physical mode of action (U.S. Food and Drug Administration, n.d.-a). Simethicone has come a long way from an industrial antifoam. Household over-the-counter medicine like Gelusil, Digene, Alka-Seltzer, all use simethicone. Today, simethicone manufacturing is where process optimization meets compliance, ensuring that every drop and every tablet performs exactly as intended: to break foam, release gas, and bring relief, affordably. With ongoing process innovations and broader global adoption, simethicone continues to find new applications across pharmaceuticals, food, and specialty materials.

Today, the global market for simethicone exceeds USD 500–600 million annually, across pharmaceutical and industrial applications (Grand View Research, 2024; Verified Market Report, n.d.). Its inclusion in multiple pharmacopeias underscores its proven record of purity, performance, and regulatory confidence. As a result, simethicone is now among the most consistently specified actives and excipients in gastrointestinal formulations worldwide.

At Thurs Organics, we take pride in carrying this legacy forward—producing high-purity, pharmacopeia-grade simethicone with consistency and care. Our commitment is simple: to make the future of simethicone as smooth and steady as the comfort it brings.